Among patients with A-fib who are treated for ACS or undergo elective PCI, it’s possible that some will benefit from up to 30 days of aspirin on top of a P2Y12 inhibitor and oral anticoagulant, post ...

Aspirin is still overprescribed for stroke prevention in atrial fibrillation (AF) despite the potential for dangerous side effects, according to new research.

MONDAY, June 20, 2016 -- More than one-third of U.S. patients with the abnormal heartbeat atrial fibrillation who need a blood thinner to prevent strokes aren't getting one, researchers say.

Long-term aspirin use doesn't lower risk of stroke for some a-fib patients. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2017 / 05 / 170514075052.htm ...

Risk Highest With VKA, No Aspirin. AUGUSTUS enrolled patients who had A-fib and were eligible for chronic oral anticoagulation, presented either with an ACS or for elective PCI, and had planned use of ...

For those patients with atrial fibrillation (Afib, AF) who were considered low risk, it was felt that aspirin provided some benefit in preventing the clots that fly out of the heart (and land in ...

At 2 years, the rates of permanent discontinuation of the study medication were 17.9% per year in the apixaban group and 20.5% per year in the aspirin group; the risk of permanent discontinuation ...

More than one-third of patients with atrial fibrillation (AF) who are have a moderate to high risk for stroke are being treated with aspirin, even though it is well known that blood thinners are ...

Many people with AFib and blood clots may be unnecessarily prescribed both a blood thinner and aspirin, a new study has found. Photo by agilemktg1/Flickr ...

Level 2: Mid-level evidence Patients with atrial fibrillation (AF) who are unable to take warfarin for stroke prophylaxis frequently take aspirin instead. The Atrial Fibrillation Clopidogrel Trial ...

The anticoagulants apixaban and dabigatran do not cause more bleeding than aspirin when treating stroke or atrial fibrillation, according to an analysis of randomized clinical trials published in ...